New data highlighting the efficacy and safety outcomes of third‐generation EGFR‐TKI in NSCLC patients with rare EGFR mutations
oleh: Weisan Zhang, Fengtan Li, Wenyuan Gao
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2020-03-01 |
Deskripsi
No description available for this item.